Ferritinophagy: A novel insight into the double‐edged sword in ferritinophagy–ferroptosis axis and human diseases
Cell Proliferation · 2024-07 · 57 (7)
DOI: 10.1111/cpr.13621 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 23.02.2024. Verfasst von Jing-Yan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Ferroptosis, Ferritins, Nuclear Receptor Coactivators, Autophagy. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, The Provincial Key Project of Medical Science Research of Hebei.
Abstract (Originalsprache)
Nuclear receptor coactive 4 (NCOA4), which functions as a selective cargo receptor, is a critical regulator of the particularly autophagic degradation of ferritin, a process known as ferritinophagy. Mechanistically, NCOA4‐mediated ferritinophagy performs an increasingly vital role in the maintenance of intracellular iron homeostasis by promoting ferritin transport and iron release as needed. Ferritinophagy is not only involved in iron‐dependent responses but also in the pathogenesis and progression of various human diseases, including metabolism‐related, neurodegenerative, cardiovascular and infectious diseases. Therefore, ferritinophagy is of great importance in maintaining cell viability and function and represents a potential therapeutic target. Recent studies indicated that ferritinophagy regulates the signalling pathway associated with ferroptosis, a newly discovered type of cell death characterised by iron‐dependent lipid peroxidation. Although accumulating evidence clearly demonstrates the importance of the interplay between dysfunction in iron metabolism and ferroptosis, a deeper understanding of the double‐edged sword effect of ferritinophagy in ferroptosis has remained elusive. Details of the mechanisms underlying the ferritinophagy–ferroptosis axis in regulating relevant human diseases remain to be elucidated. In this review, we discuss the latest research findings regarding the mechanisms that regulate the biological function of NCOA4‐mediated ferritinophagy and its contribution to the pathophysiology of ferroptosis. The important role of the ferritinophagy–ferroptosis axis in human diseases will be discussed in detail, highlighting the great potential of targeting ferritinophagy in the treatment of diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Orthopedics, Hebei Provincial Chidren's Hospital, Shijiazhuang, China.
- Translational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Jing-Yan Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
- The Provincial Key Project of Medical Science Research of Hebei
- The Training Project of Government Funded Clinically Outstanding Personnel in Medicine
Zitieren
APA
Li, J. Y., Feng, Y. H., Li, Y. X., He, P. Y., Zhou, Q. Y., Tian, Y. P., Yao, R. Q., & Yao, Y. M. (2024). Ferritinophagy: A novel insight into the double‐edged sword in ferritinophagy–ferroptosis axis and human diseases. Cell Proliferation, 57(7). https://doi.org/10.1111/cpr.13621
Vancouver
Li JY, Feng YH, Li YX, He PY, Zhou QY, Tian YP, et al. Ferritinophagy: A novel insight into the double‐edged sword in ferritinophagy–ferroptosis axis and human diseases. Cell Proliferation. 2024;57(7). doi:10.1111/cpr.13621
BibTeX
@article{Li2024,
author = {Li, Jing-Yan and Feng, Yan-Hua and Li, Yu-Xuan and He, Peng-Yi and Zhou, Qi-Yuan and Tian, Ying-Ping and Yao, Ren-Qi and Yao, Yong-Ming},
title = {Ferritinophagy: A novel insight into the double‐edged sword in ferritinophagy–ferroptosis axis and human diseases},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {7},
doi = {10.1111/cpr.13621}
}
EUVIMED